Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Essex Woodlands Healthcare Partners

Founders Jim Currie Marty Sutter

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 110
Average round size
info
The average size of a deal this fund participated in
$37M
Portfolio companies 73
Rounds per year 2.82
Lead investments 34
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.34
Exits 46
Key employees 6
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Pharmaceutical
Summary

In 1985 was created Essex Woodlands Healthcare Partners, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Palo Alto.

Among the most popular fund investment industries, there are Biopharma, Hospital. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Inhibitex, Catalyst Biosciences, ikaSystems. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Essex Woodlands Healthcare Partners, startups are often financed by SV Health Investors, Johnson & Johnson Development Corporation, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are SV Health Investors, Novo Holdings, MPM Capital. In the next rounds fund is usually obtained by Johnson & Johnson Development Corporation, Novo Holdings, MPM Capital.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2014. Opposing the other organizations, this Essex Woodlands Healthcare Partners works on 6 percentage points more the average amount of lead investments. The fund is constantly included in 2-6 investment rounds annually. The important activity for fund was in 2009. Despite it in 2019 the fund had an activity. The typical startup value when the investment from Essex Woodlands Healthcare Partners is 10-50 millions dollars. The real fund results show that this VC is 26 percentage points more often commits exit comparing to other companies.

The fund was created by Jim Currie, Marty Sutter. We also calculated 6 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Essex Woodlands Healthcare Partners:
Typical Co-investors
Essex Woodlands Healthcare Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Essex Woodlands Healthcare Partners:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Tissuetech

Biotechnology
Health Care
Medical
Medical Device
Pharmaceutical
$82M26 Jun 2019 Miami, Florida, United States

Kona Medical

Health Care
Medical
Therapeutics
$10M04 Dec 2012 Bellevue, Washington, United States

Kona Medical

Health Care
Medical
Therapeutics
$30M30 May 2012 Bellevue, Washington, United States

IntegenX

Biotechnology
Health Diagnostics
$40M13 Dec 2011 California, United States

BreatheAmerica

Biotechnology
Clinics/Outpatient Services
Health Care
Medical Device
$22M06 Sep 2011 Nashville, Tennessee, United States

TearScience

Biotechnology
Clinical Trials
Health Care
Medical
Medical Device
$44M06 May 2010 North Carolina, United States

Molecular Partners

Biotechnology
Medical
Pharmaceutical
$44M16 Dec 2009 Zurich, Zurich, Switzerland

Oraya Therapeutics

Biotechnology
Health Care
Medical Device
$42M20 Jul 2009 California, United States

Nellix

Health Care
Medical Device
$6M15 Mar 2008 Palo Alto, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Essex Woodlands Healthcare Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 110
Average round size 37M
Rounds per year 2.82
Peak activity year 2007
Lead investments 34
Follow on index 0.34
Exits 46
Group Appearance index 0.71

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Tissuetech

Biotechnology
Health Care
Medical
Medical Device
Pharmaceutical
$82M26 Jun 2019 Miami, Florida, United States

Kona Medical

Health Care
Medical
Therapeutics
$10M04 Dec 2012 Bellevue, Washington, United States

Kona Medical

Health Care
Medical
Therapeutics
$30M30 May 2012 Bellevue, Washington, United States

IntegenX

Biotechnology
Health Diagnostics
$40M13 Dec 2011 California, United States

BreatheAmerica

Biotechnology
Clinics/Outpatient Services
Health Care
Medical Device
$22M06 Sep 2011 Nashville, Tennessee, United States

TearScience

Biotechnology
Clinical Trials
Health Care
Medical
Medical Device
$44M06 May 2010 North Carolina, United States

Molecular Partners

Biotechnology
Medical
Pharmaceutical
$44M16 Dec 2009 Zurich, Zurich, Switzerland

Oraya Therapeutics

Biotechnology
Health Care
Medical Device
$42M20 Jul 2009 California, United States

Nellix

Health Care
Medical Device
$6M15 Mar 2008 Palo Alto, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: